TALOPH(SH:600222) Zheng Quan Zhi Xing·2025-08-15 11:17Meeting Overview - The shareholders' meeting of Henan Tailong Pharmaceutical Co., Ltd. was held on August 15, 2025, at the company's conference room in Zhengzhou High-tech Industrial Development Zone [1] - The meeting was convened by the board of directors and chaired by Chairman Yin Hui, utilizing a combination of on-site and online voting methods [1][3] - All procedures for convening and conducting the meeting complied with the Company Law and the company's articles of association, ensuring the legality and validity of the resolutions [3][4] Voting Results - Non-cumulative voting resolutions were all passed with significant support, including: - A total of 151,054,504 votes (98.4456%) in favor, 1,343,931 votes (0.8759%) against, and 1,041,100 votes (0.6785%) abstaining for the first resolution [1] - Similar high approval rates were observed for subsequent resolutions, with votes in favor consistently above 98% [1][2] - Cumulative voting for the election of directors also showed strong support, with 151,676,834 votes (98.8512%) in favor for the election of non-independent directors [2] Legal Compliance - The meeting's resolutions were confirmed to be legally valid, as they met the required thresholds for special and ordinary resolutions, with over two-thirds and half of the voting rights respectively [3][4] - Legal representatives confirmed that all aspects of the meeting adhered to relevant laws and regulations, ensuring the integrity of the proceedings [4]